Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 7
Submit an article Journal homepage
350
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

EBV-positive Richter’s syndrome with laboratory features of Burkitt’s lymphoma, in Ibrutinib-treated chronic lymphocytic leukemia

Mohammad O. HussainiDepartment of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center, Tampa, FL, USA;
,
Alman RehmanUniversity of Central Florida, Orlando, FL, USA;
,
Julio C. ChavezDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA;
,
Javier Pinilla-IbarzDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA;
&
Pedro HornaDivision of Hematopathology, Mayo Clinic, Rochester, MN, USACorrespondence[email protected]
Pages 1753-1756 | Received 20 Jul 2016, Accepted 27 Oct 2016, Published online: 16 Nov 2016

References

  • Müller-Hermelink HK, Montserrat E, Catovsky D, et al. Chronic lymphocytic leukemia/small lymphocytic lymphoma. In: Swerdlow SH, Campo E, Lee Harris N, et al. editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC; 2008.
  • Jamroziak K, Tadmor T, Robak T, et al. Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy. Leuk Lymphoma. 2015;56:1949–1958.
  • Pinilla-Ibarz J, Chavez JC. Life after ibrutinib? A new unmet need in CLL. Blood. 2015;125:2013–2014.
  • Flatley E, Chen AI, Zhao X, et al. Aberrations of MYC are a common event in B-cell prolymphocytic leukemia. Am J Clin Pathol. 2014;142:347–354.
  • Huh YO, Lin KI, Vega F, et al. MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis. Br J Haematol. 2008;142:36–44.
  • Li Y, Hu S, Wang SA, et al. The clinical significance of 8q24/MYC rearrangement in chronic lymphocytic leukemia. Mod Pathol. 2016;29:444–451.
  • Asirvatham JR, Brody J, Vora R, et al. Prognostic significance of isolated t(8:14) in chronic lymphocytic leukemia. Leuk Lymphoma. 2014;55:685–688.
  • Rossi D, Spina V, Deambrogi C, et al. The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. Blood. 2011;117:3391–3401.
  • Fabbri G, Khiabanian H, Holmes AB, et al. Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome. J Exp Med. 2013;210:2273–2288.
  • Chigrinova E, Rinaldi A, Kwee I, et al. Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome. Blood. 2013;122:2673–2682.
  • Woroniecka R, Rymkiewicz G, Grygalewicz B, et al. Cytogenetic and flow cytometry evaluation of Richter syndrome reveals MYC, CDKN2A, IGH alterations with loss of CD52, CD62L and increase of CD71 antigen expression as the most frequent recurrent abnormalities. Am J Clin Pathol. 2015;143:25–35.
  • Kroft SH, Dawson DB, McKenna RW. Large cell lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. A flow cytometric analysis of seven cases. Am J Clin Pathol. 2001;115:385–395.
  • Mohamed AN, Compean R, Dan ME, et al. Clonal evolution of chronic lymphocytic leukemia to acute lymphoblastic leukemia. Cancer Genet Cytogenet. 1996;86:143–146.
  • Asou N, Osato M, Horikawa K, et al. Burkitt's type acute lymphoblastic transformation associated with t(8;14) in a case of B cell chronic lymphocytic leukemia. Leukemia. 1997;11:1986–1988.
  • Maddocks KJ, Ruppert AS, Lozanski G, et al. Etiology of ibrutinib therapy discontinuation and outcomes in patients with chronic lymphocytic leukemia. JAMA Oncol. 2015;1:80–87.
  • Jain P, Keating M, Wierda W, et al. Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib. Blood. 2015;125:2062–2067.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.